On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective

The loss of mobility is a common trait in multiple health conditions (e.g., Parkinson's disease) and is associated with reduced quality of life. In this context, being able to monitor mobility in the real world, is important. Until recently, the technology was not mature enough for this; but to...

Descripción completa

Detalles Bibliográficos
Autores principales: Viceconti, Marco, Tome, Maria, Dartee, Wilhelmus, Knezevic, Igor, Hernandez Penna, Sabina, Mazzà, Claudia, Caulfield, Brian, Garcia-Aymerich, Judith, Becker, Clemens, Maetzler, Walter, Troosters, Thierry, Sharrack, Basil, Davico, Giorgio, Corriol-Rohou, Solange, Rochester, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533102/
https://www.ncbi.nlm.nih.gov/pubmed/36213641
http://dx.doi.org/10.3389/fmed.2022.996903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533102/
https://www.ncbi.nlm.nih.gov/pubmed/36213641
http://dx.doi.org/10.3389/fmed.2022.996903

Ejemplares similares